News

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, sent a letter to National Collegiate Athletic Association (NCAA) President Charlie Baker following the recent announcement that student athletes and athletic department staff will be allowed to bet on professional sports. KEY EXCERPTS: “The Committee on Energy and Commerce is examining the NCAA’s recent policy change permitting student athletes and athletic department staff to bet on professional sports.” [...] To assist the Committee in its oversight, we request a briefing by no later than November 13, 2025, that addresses the following: Why is the NCAA changing its policy allowing student athletes to bet on professional sports? Has the NCAA conducted any studies, analyses, or reviews of the impact of gambling on student athletes? If so, what are the results? What role did they play in the NCAA’s decision to allow student athletes to bet on professional sports? How does this change allow the NCAA, the conferences, and the member schools to better protect the integrity of college games and encourage healthy habits for student-athletes who choose to engage in betting activities on professional sports? How is the NCAA engaging with athletic conferences, member institutions, and teams to address questions and concerns about this rule change? Amid recent allegations of illegal sports betting among student athletes and concerns expressed by member institutions, is NCAA reconsidering implementation of the policy? What guardrails are in place to prevent the type of illegal sports betting activity that is allegedly occurring in the NCAA and NBA, considering that some student athletes will go on to become professional athletes? Please provide details about any fraudulent, illegal, and alleged betting practices in connection with NCAA players, coaches, and officials, including the actions of NCAA players identified in recent infraction decisions; as well as prior instances, some of which are identified above. Please describe the NCAA’s “layered integrity monitoring program,” for maintaining competition integrity and pursuing sports betting violations. What gaps, if any, are in existing regulations that allow illegal betting schemes to occur in college sports? BACKGROUND: On October 24, 2025, the Committee on Energy and Commerce launched its investigation into sports fixing and illegal gambling after the Federal Bureau of Investigation (FBI) unsealed indictments of current and former NBA players and coaches. An initial announcement stated that, effective November 1, 2025, student athletes and athletic department staff in all three NCAA divisions would be permitted to bet on professional sports. A few days before the policy change was supposed to take effect, the Division I Board of Directors voted to delay implementation of the rule change across all three divisions to November 22, 2025. A recent NCAA press release stated that “enforcement staff has opened investigations into potential sports betting violations by approximately 30 current or former men's basketball student-athletes.” CLICK HERE to read the full letter.

WASHINGTON, D.C. – Today, House Committee on Energy and Commerce Chairman Brett Guthrie (KY-02) and Ranking Member Frank Pallone Jr., (NJ-06), along with Energy and Commerce Subcommittee on Oversight and Investigations Chairman John Joyce, M.D. (PA-13) and Ranking Member Yvette D. Clarke (NY-09), and Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade Chairman Gus Bilirakis (FL-12) and Ranking Member Jan Schakowsky (IL-09), sent a letter to National Basketball Association (NBA) Commissioner Adam Silver following the recent announcement that current and former NBA players and coaches have been indicted on charges relating to sports fixing and illegal gambling. KEY EXCERPT: These allegations raise serious concerns about sports betting and the integrity of sport in the NBA, which harms fans and legal sports bettors. [...] To assist the Committee in its oversight, we request a briefing by no later than October 31, 2025, that addresses the following:  Details about the fraudulent, illegal, and alleged betting practices in connection with NBA players, coaches, and officials, including the actions of NBA players and coaches identified in the recent indictment; as well as prior instances, some of which are identified above.  Actions the NBA intends to take to limit the disclosure of nonpublic information for illegal purposes. Whether the NBA’s Code of Conduct for players and coaches effectively prohibits illegal activity, including the disclosure of non-public information for the purposes of illegal betting schemes. An explanation of the gaps, if any, in existing regulations that allow illegal betting schemes to occur. Whether and how the NBA is reevaluating the terms of its partnerships with sports betting companies. BACKGROUND: According to the unsealed indictment, current and former NBA players and coaches allegedly used insider information to place or profit from bets on NBA games. The federal indictment’s allegations of illegal betting span incidents of fraudulent wagering from December 2022 to March 2024 and involve defendants and co-conspirators residing across the United States. In 2023, it is alleged that Miami Heat player Terry Rozier left a game early to facilitate a co-conspirator’s winning bet, which produced hundreds of thousands of dollars in winnings to be split with Mr. Rozier. Another co-conspirator, former NBA player Damon Jones, is alleged to have gained access to non-public information on NBA players and teams, which he then sold to professional gamblers. Other unnamed co-conspirators are alleged to have passed along insider information as well, such as which players would not be playing in an upcoming game. In 2007, former NBA referee Tim Donaghy pleaded guilty to federal charges for using insider information to bet on games he officiated. Last year, Toronto Raptors player Jontay Porter was banned from the NBA for life after pleading guilty to wire fraud conspiracy due to his involvement in a sports betting scandal. CLICK HERE to read the full letter. CLICK HERE to read ESPN's exclusive coverage of the letter.

WASHINGTON, D.C.  – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, and Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, sent letters to Pam Bondi, U.S. Attorney General, Andrew Ferguson, Chairman of the Federal Trade Commission, and Howard Lutnick, Secretary of the U.S. Department of Commerce, urging the administration to investigate and address potential national security risks posed by BrainCo, a neural technology company allegedly funded by the People’s Republic of China (PRC). KEY EXCERPTS: “The Committee on Energy and Commerce has long warned about the national and economic security risks of CCP-aligned entities accessing Americans’ personal and proprietary information. The use of American data by CCP-aligned entities, such as BrainCo, to develop and deploy AI underscores our concerns. […] The Committee urges swift action to investigate and address the potential national and economic security risks posed by BrainCo’s operations in the United States and its access to Americans’ personal information.” BACKGROUND: According to recent reporting , the company was started by MIT and Harvard scientists but has “been quietly backed by the Chinese government-linked entities for nearly a decade.”  BrainCo products reportedly harvest personalized brainwave data from users.  BrainCo is reportedly working with sanctioned PRC military contractors.  BrainCo products reportedly have been used by Olympic gold medalist Mikaela Shiffrin, number two world tennis player, Jannik Sinner, U.S. Olympic teams, and many others.  Along with DeepSeek , BrainCo is considered one of China’s “Six Little Dragons” — meaning one of the CCP’s most promising young tech startups. The PRC’s National Intelligence Law of 2017 requires PRC individuals and entities to support PRC intelligence services. CLICK HERE to read exclusive coverage of the letter. CLICK HERE to read the Hunterbrook Media story on their investigation into BrainCo. CLICK HERE to listen to the corresponding Pablo Torre Finds Out podcast episode. CLICK HERE to read the letters to Attorney General Bondi, Chairman Ferguson, and Secretary Lutnick. ###

WASHINGTON, D.C.  – In case you missed it, the Washington Examiner published an article featuring a letter from House Committee on Energy and Commerce Chairman Brett Guthrie (KY-02) and Ranking Member Frank Pallone Jr. (NJ-06), along with Energy and Commerce Subcommittee on Oversight and Investigations Chairman John Joyce, M.D. (PA-13), and Ranking Member Yvette D. Clarke (NY-09), requesting a briefing on HRSA’s ongoing oversight of patient safety in the nation’s organ procurement and transplant system. In Case You Missed It: “House Republicans and Democrats are pressing the Department of Health and Human Services to increase transparency on possible ‘systemic problems’ and ‘threats to patient safety’ in the national organ transplant system, according to a letter obtained by the Washington Examiner. “Bipartisan leadership on the Energy and Commerce Committee wrote to Health Resources and Services Administrator Thomas Engels on Friday, probing whether the agency is able to conduct a wide-ranging review of patient safety after multiple reported incidents of organ donor patients being egregiously mistreated by organ procurement organizations. “Chairman Brett Guthrie (R-KY), along with ranking Democratic Rep. Frank Pallone (NJ), John Joyce (R-PA), and Yvette Clarke (D-NY), said in a joint statement on Tuesday that their investigation into the organ procurement system ‘has demonstrated the need for further oversight’ and that problems may exist nationwide. “The American people should be able to have full faith and confidence in our organ donor and transplant system, and we will continue to work together to prevent these harmful practices from continuing,’ said the bipartisan representatives in their statement. “The Energy and Commerce Committee began its longer-term investigation testimony last fall about a Kentucky patient, Anthony Thomas Hoover II, whose family agreed to proceed with organ donation following an overdose in 2021. “Although Hoover’s neurological condition improved, representatives from the Kentucky Organ Donor Affiliates, the organ procurement organization serving Kentucky, moved forward with the organ retrieval process. Records indicate that Hoover woke up on the operating table before the retrieval surgery, and hospital staff intervened to stop the procedure. “HRSA, which oversees the national Organ Procurement and Transplantation Network and its contractor organ procurement organizations, conducted its own internal investigation into the Kentucky situation following the revelation of Hoover’s case. “The HRSA corrective action plan, issued in May, examined 351 organ procurement cases in Kentucky between December 2024 and February 2025 that did not result in donation. “About 30% of those cases, 103 patients, presented ‘concerning features,’ including 73 patients who showed neurological signs of life after being approved for organ donation surgery and 28 patients who may have survived entirely since there was no cardiac time of death recorded. “Other ‘concerning features’ of the incidents in the HRSA report, according to Guthrie and his House colleagues, include ‘issues related to patient and family interactions, medical assessments and healthcare team interactions, recognition of high neurological function, and recognition and documentation of drugs in patient records.’ “HRSA’s testimony and other public reports suggest that these patterns are not limited to instances detailed in HRSA’s report and may exist in other parts of the country,’ Guthrie and his colleagues wrote. “The bipartisan representatives in their letter cited a New York Times piece published in August about Misty Hawkins, 42, from Alabama, who was taken off life support in the spring of 2024 and prepped for organ donation. Doctors discovered while she was on the operating table that her heart was still beating and she was breathing during her organ retrieval surgery. “Last week, another story came to light of a 22-year-old patient from Kentucky who, in 2019, was taken to surgery to have his organs removed for donation despite still having a heartbeat and not being declared brain dead. “Larry Black Jr., who arrived at the hospital a week prior due to a gunshot wound to the head, was rescued from surgery just in time by another physician. Now at 28, he is a father to three children. “HHS Secretary Robert F. Kennedy Jr. directed HRSA in July to conduct a deeper investigation into the Kentucky organ procurement case, saying that ‘the entire system must be fixed to ensure that every potential donor’s life is treated with the sanctity it deserves.’ “But the agency has not yet announced plans for a nationwide review of organ transplant systems. “Guthrie and his House colleagues requested that HRSA provide more information on the current status of all patient safety complaints that the agency has received and whether or not HRSA has the capacity ‘to initiate other wide-ranging reviews appropriate, in response to a patient safety complaint that may suggest a systemic problem.’ “The committee requested a staff-level briefing no later than September 26. “Americans’ confidence in the system comes when patient safety is protected,’ said the bipartisan House coalition.”   ###

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, issued the following statement in response to an announcement by the Department of Health and Human Services (HHS) of a decision to decertify the organ procurement organization (OPO) covering South Florida, as well as new efforts by the Health Services and Resources Administration’s (HRSA) to improve operations within the organ procurement and transplant system. “It is critical to ensure that all entities involved in the organ procurement and transplantation process operate safely, and we are grateful to HHS for their instrumental action taken today to mitigate some of the harmful practices that have come to light through rigorous investigations by this Committee and HRSA,” said Chairmen Guthrie and Joyce. “The Energy and Commerce Subcommittee on Oversight and Investigations held a hearing on issues related to patient safety in July and will continue working to protect patients and their families to restore trust in our nation’s organ procurement and transplant system. We applaud HHS for building upon those efforts through the actions taken today and look forward to continuing to work with them.”   Background:   Today, HHS announced it is moving to decertify an Organ Procurement Organization (OPO)—the Life Alliance Organ Recovery Agency, a division of the University of Miami Health System—after an investigation uncovered years of unsafe practices, poor training, chronic underperformance, understaffing, and paperwork errors.  HHS also announced reforms to restore integrity and trust in the Organ Procurement and Transplantation Network (OPTN), including:  Imposing safeguards to prevent line-skipping in organ allocation, immediately protecting nearly 300 patients.  Holding a special election, which spurred record turnout, to install an independent OPTN board.  Establishing a strengthened misconduct reporting system, giving patients and providers a direct channel for safety concerns.  Creating a transparency tool that shows when organs are allocated outside the standard match list.  Removing “DEI” provisions from the 2024 IOTA model to ensure procedural fairness.  Through its extensive investigation, the House Committee on Energy and Commerce has uncovered concerning practices in our nation’s organ procurement and transplant system.   On July 22, 2025, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a hearing examining concerning practices within our nation’s organ procurement and transplant system that were also identified by HRSA’s investigation.    On September 12, 2025, Chairmen Guthrie and Joyce and Ranking Members Pallone and Clarke wrote a letter to HRSA requesting a briefing on its ongoing oversight of patient safety in our nation’s organ procurement and transplant system.  ###

WASHINGTON, D.C.  – House Committee on Energy and Commerce Chairman Brett Guthrie (KY-02) and Ranking Member Frank Pallone Jr., (NJ-06), along with Energy and Commerce Subcommittee on Oversight and Investigations Chairman John Joyce, MD (PA-13), and Ranking Member Yvette D. Clarke (NY-09), wrote to the Health Resources and Services Administration (HRSA) requesting a briefing on its ongoing oversight of patient safety in our nation’s organ procurement and transplant system.   In July, the Committee’s Oversight and Investigations Subcommittee held a hearing in response to a HRSA investigative report that found patient safety concerns at Kentucky Organ Donor Affiliates (KYDA) – the organ procurement organization (OPO) serving the state of Kentucky. In the investigative report, HRSA revealed that of the 351 cases reviewed, 103 cases (29.3 percent) showed “concerning features.” These concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.   In addition, HRSA issued a corrective action plan to address the findings in its report specific to KYDA and directing the Organ Procurement and Transplantation Network (OPTN) Board of Directors to develop certain safety guidelines for the entire OPTN. The corrective action plan raised further questions about the possibility that there may be more systemic issues at OPOs across the country, noting that “ [s]ince the review of KYDA was initiated, HRSA has received reports of similar patterns of high risk [donation after circulatory death] procurement practices at other OPOs .” Moreover, during the July hearing, HRSA’s Organ Transplant Branch Chief, Dr. Raymond Lynch was questioned about the potential failure to adhere to existing protocols by Rep. Erin Houchin (IN-09): “ is it a broader systemic issue or is it limited to KYDA ?” Dr. Lynch responded that “ [u]nfortunately, it is not limited to KYDA. During the course of this investigation we received concerns that were in areas served by other OPOs. ”  Chairmen Guthrie and Joyce and Ranking Members Pallone and Clarke issued the following joint statement:    “ The Committee’s examination of the organ procurement and transplant system has demonstrated the need for further oversight.  Testimony from the July hearing, HRSA’s investigative report and corrective action plan, and continued reports of similar patterns at other OPOs all raise serious concerns. The American people should be able to have full faith and confidence in our organ donor and transplant system, and we will continue to work together to prevent these harmful practices from continuing. Americans’ confidence in the system comes when patient safety is protected. ”    Read the full letter  here . Background:  ·       During the 118th Congress, the Committee on Energy and Commerce  passed  the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the OPTN and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.   ·       On March 20, 2024, the Committee  launched an investigation  into the organ procurement and transplantation system by sending  a letter  to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.    ·       On March 20, 2024, the Committee also sent  a letter  to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.   ·       On September 11, 2024, the Subcommittee on Oversight and Investigations held a  hearing  that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.   ·       During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA’s March 2025 report.   ·       On March 24, 2025, HRSA’s Division of Transplantation issued a  report  that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virgina, and Indiana.  ·       On May 28, 2025, HRSA issued a  CAP  to OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.   ·       On July 22, 2025, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a  hearing  examining concerning practices within our nation’s organ procurement and transplant system that were identified by HRSA’s investigation.   ###

WASHINGTON, D.C.  – Last month, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a hearing diving deeper into concerning practices within our nation’s organ procurement and transplant system that were identified by a recent Health Resources and Services Administration (HRSA) investigation. During the two-panel hearing titled “Ensuring Patient Safety: Oversight of the U.S. Organ Procurement and Transplant System,” Committee Members heard from the Chief of the Organ Transplant Branch of HRSA regarding the agency’s recently released investigative report outlining shocking revelations about the system’s procedures that put patient safety at risk. The investigation examined an “index case” (KYDA-001) where the organ procurement organization (OPO) that services Kentucky was contacted shortly after the arrival of a patient who was experiencing cardiovascular collapse after an unintentional overdose. After it was determined that further treatment would be futile, the patient’s family made the decision to end life-sustaining treatment and move forward with organ donation via a process known as donation after cardiac (or circulatory) death (DCD). However, despite OPO and hospital staff noting signs of the patient’s improved neurologic function, discomfort, and even expression of fear at multiple points over the multi-day period between when the OPO was first contacted and the patient was brought to the operating room (OR), the decision to pursue organ recovery was not reversed until the physician in the OR became uncomfortable and refused to continue with the process. In addition to the index case, HRSA analyzed 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for DCD recovery, but no organs were transplanted. The report shows that 103 of these cases, which is nearly 30 percent, “had concerning features.”  HRSA’s Organ Transplant Branch Chief, Dr. Raymond Lynch, testified about KYDA’s (Network for Hope) patterns that were identified in the report, which include: A failure to recognize neurologic function inconsistent or unfavorable for DCD organ recovery on initial patient assessment or subsequent follow up; A failure to work collaboratively with patients’ primary medical teams, including instances of potential violation of separation of roles in patient care; A failure to respect family wishes and appropriately safeguard the decision-making authority of legal next of kin; and A failure to follow professional best practices as well as policies and guidelines for collection of patients’ medical data. The second panel included witnesses from “Network for Hope,” the OPO involved in all of the cases that HRSA reviewed; the United Network for Organ Sharing (UNOS); and the current and recent past President of the Organ Procurement and Transplantation Network (OPTN) Board of Directors.  Chairman Joyce probed Network for Hope CEO, Mr. Barry Massa, for using the word “unique” to describe the index case, the same case where “...hospital staff [felt] extremely uncomfortable with the amount of reflexes patient is exhibiting,” during the procurement process. Congressman Gary Palmer (AL-06) questioned witnesses about an open letter that was issued after the Subcommittee’s September 2024 hearing and signed by the organ donation and transplant industry and community members, including individuals at UNOS and OPTN Board Members. The open letter, per HRSA’s report, “characterized the ongoing effort to improve patient safety through enhanced oversight as a ‘misinformation campaign,’” noting that “[i]t is time for it to stop.” Specifically, the letter portrayed the previous oversight efforts by this Committee as “[s]preading misinformation based on conspiracy theories and hearsay.” UNOS’s CEO, Dr. Maureen McBride, admitted to signing the letter.  The Committee has serious concerns about the message this letter sends both to those conducting oversight of the organ procurement and transplant system and to those who wish to speak up when they wish to report concerns or potential wrongdoing. Oversight of this issue is far from over, and the Committee remains committed to protecting patient safety and maintaining trust in the system to ensure transparency and accountability. As Chairman Guthrie said when recalling his personal experience with our nation’s organ procurement and transplant system, “The conclusion [of this process] is going to come when we have confidence in the system.” ###

WASHINGTON, D.C.  – In case you missed it, Fox News recently published an article featuring a letter from Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, and John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, requesting information on California’s decision to continue imposing a de-facto EV mandate. In Case You Missed It: “In a sharp rebuke, a Kentucky congressman is pressing California’s top environmental agency for answers after learning the state may be ignoring Congress’ reversal of three key electric vehicle standards. “The House Committee on Energy and Commerce wrote to Sacramento that it is ‘concerned about reports that California, and other jurisdictions who have adopted California standards for which waivers of preemption have been granted, are enforcing preempted vehicle emission regulations in violation of the Clean Air Act.’ “Earlier this year, Congress used the Congressional Review Act to nullify Biden-era waivers granted by the Biden EPA to California, allowing them to implement stricter standards than the federal government. “Several states, including Pennsylvania and Delaware, along with the District of Columbia, have adopted California’s low-emissions standards as well. “The Committee has been made aware that CARB staff is denying auto manufacturers approval to bring vehicles to market unless the manufacturers agree to comply with the preempted regulations,’ the committee continued. “Rep. Brett Guthrie, chair of the House Energy and Commerce Committee, a Republican, told Fox News Digital that the law is clear that the Golden State must end its ‘de-facto EV mandate.’ “Enforcing a ban on the sale of gas-powered vehicles would have dire consequences for American families and businesses,’ Guthrie said. “Forcing Americans to buy these vehicles would strain our electric grid, raise costs, and increase our reliance on China. Our investigation will look into whether California is continuing to enforce an EV mandate in violation of federal law.’ Joining Guthrie on the letter were Reps. Gary Palmer, R-Ala., and John Joyce, R-Pa., chairmen of the environment and oversight subcommittees, respectively. “The committee acknowledged a lawsuit against the recissions from California Attorney General Robert Bonta remains ongoing, but that the intermission does not allow the state to continue enforcing mandates under the nixed waivers. In a June statement announcing the lawsuit, Bonta called the situation ‘reckless, politically motivated and illegal.’ “The letter, addressed to Dr. Steven Cliff, executive officer of the California Air Resources Board, said the committee had been purportedly made aware of CARB staff denying auto manufacturers’ approval to bring vehicles to market in the state ‘unless the manufacturers agree to comply with the preempted regulations.’ “These efforts include CARB staff indicating that the agency would deny California Executive Orders (EO) for model year 2026 vehicles that meet all of CARB’s enforceable regulatory requirements and which California allowed for sale in model year 2025, on the basis that these vehicles do not meet the additional requirements in one set of the preempted regulations: ACC-II.’ “The committee further alleges that CARB’s online ‘repository’ spreadsheet of model year 2026 vehicles showed the board has ‘exclusively approved’ vehicles that would certify under the ACC-II green regulations. “They closed by demanding documents showing whether CARB is continuing to enforce the car, truck or omnibus regulations Congress undid, and all records from the first of the year onward germane to the regulations and Biden-era waivers. “Fox News Digital reached out to CARB and Gov. Gavin Newsom for comment on accusations that the board is discriminating against certain vehicles.”

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, and John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, sent a letter to the California Air Resources Board, requesting information on California’s decision to continue imposing a de-facto EV mandate. “The law is clear California must put an end to its de-facto EV mandate. Enforcing a ban on the sale of gas-powered vehicles would have dire consequences for American families and businesses,” said Chairman Guthrie. “Forcing Americans to buy these vehicles would strain our electric grid, raise costs, and increase our reliance on China. Our investigation will look into whether California is continuing to enforce an EV mandate in violation of federal law.” Read more about the letter from Fox News here . Key excerpts from the letter: “The Committee is concerned about reports that California, and other jurisdictions who have adopted California standards for which waivers of preemption have been granted, are enforcing preempted vehicle emission regulations in violation of the Clean Air Act.” “The Committee has been made aware that CARB staff is denying auto manufacturers approval to bring vehicles to market unless the manufacturers agree to comply with the preempted regulations.” Background: On June 12, 2025, President Trump signed three resolutions of disapproval under the Congressional Review Act. H.J. Res. 87, H.J. Res. 88, and H.J. Res 89, which collectively disapproved California’s waiver of preemption allowing the state to impose emission standards that effectively ban the sale of new gas-powered vehicles. The CRA’s passed Congress with bipartisan support. The Clean Air Act clearly bans states from issuing their own emission standards unless EPA grants a waiver of federal preemption. Because the EPA’s waivers have been disapproved under the CRA, the California EV mandates are not allowed under the Clean Air Act. Despite three Congressional Review Act (CRA) resolutions being signed into law this year that block California from implementing vehicle standards that ban the sale of gas-powered cars and trucks through its Advanced Clean Cars (ACC) II regulations, Advanced Clean Trucks (ACT) regulations, and Omnibus Low NOx programs (the Omnibus) regulations, Committee staff have learned that California and other states are continuing to implement the preempted rules. Specifically, following formal disapproval of previously granted waivers due to the CRAs, California is reportedly refusing to certify automobiles that don’t meet the now-preempted standards, contrary to federal law, i.e., the Clean Air Act. CLICK HERE to read the full letter.